- in an analysis of clinical trials, the most commonly prescribed group of migraine drugs failed to relieve headaches in 24% to 68% of attacks
- The review found that all marketed tripants provided significant relief and/or absence of pain at 1 and 2 hours when compared with placebo. however, the analysis also showed that 24% to 68% of migranes failed to respond to these medications.


